AKT1 and Parkinson disease: The alteration of the PI3K/Akt pathway, which leads to the overexpression or the inactivation of TOR kinase, seems to be critical in a number of diseases, such as cancer and diabetes (Ali et al., 2017), or neurological diseases such as Parkinson (Xu et al., 2014; Tiwari and Pal, 2017) and Alzheimer (Tang et al., 2015; Tramutola et al., 2015).